• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate.在接受三钾二枸橼酸铋治疗的患者中,D-青霉胺不会增加尿铋排泄。
Br J Clin Pharmacol. 1990 Oct;30(4):648-50. doi: 10.1111/j.1365-2125.1990.tb03829.x.
2
Tripotassium dicitrato bismuthate: absorption and urinary excretion of bismuth in patients with normal and impaired renal function.
Aliment Pharmacol Ther. 1991 Oct;5(5):491-502. doi: 10.1111/j.1365-2036.1991.tb00518.x.
3
Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate.
Aliment Pharmacol Ther. 1989 Feb;3(1):21-8. doi: 10.1111/j.1365-2036.1989.tb00187.x.
4
Omeprazole-induced increase in the absorption of bismuth from tripotassium dicitrato bismuthate.奥美拉唑引起的三钾二枸橼酸铋中铋吸收增加。
Clin Pharmacol Ther. 1994 May;55(5):486-91. doi: 10.1038/clpt.1994.61.
5
The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate.口服三枸橼酸铋钾后铋的吸收情况。
Aliment Pharmacol Ther. 1989 Feb;3(1):29-39. doi: 10.1111/j.1365-2036.1989.tb00188.x.
6
Studies on the absorption and excretion of tripotassium dicitrato-bismuthate in man.
Res Commun Chem Pathol Pharmacol. 1981 Nov;34(2):359-64.
7
Lack of evidence of neurotoxicity following 8 weeks of treatment with tripotassium dicitrato bismuthate.用枸橼酸铋钾三水合物治疗8周后未发现神经毒性证据。
Aliment Pharmacol Ther. 1994 Feb;8(1):45-53. doi: 10.1111/j.1365-2036.1994.tb00159.x.
8
Comparison of plasma bismuth levels after oral dosing with basic bismuth carbonate or tripotassium dicitrato bismuthate.
Aliment Pharmacol Ther. 1992 Apr;6(2):241-9. doi: 10.1111/j.1365-2036.1992.tb00267.x.
9
Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.枸橼酸铋钾片或西咪替丁治疗十二指肠溃疡的效果。
Gut. 1983 Dec;24(12):1148-51. doi: 10.1136/gut.24.12.1148.
10
Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).新型抗溃疡药枸橼酸铋雷尼替丁(GR122311X)与三钾二枸橼酸铋(TDB)中铋的比较药代动力学。
Eur J Clin Pharmacol. 1994;47(2):177-80. doi: 10.1007/BF00194969.

本文引用的文献

1
Antidotes for acute bismuth intoxication.急性铋中毒的解毒剂。
J Toxicol Clin Toxicol. 1983 Apr;20(2):159-65. doi: 10.3109/15563658308990060.
2
DMSA and DMPS--water soluble antidotes for heavy metal poisoning.二巯基丁二酸和二巯基丙磺酸钠——重金属中毒的水溶性解毒剂。
Annu Rev Pharmacol Toxicol. 1983;23:193-215. doi: 10.1146/annurev.pa.23.040183.001205.
3
Reversible encephalopathy possibly associated with bismuth subgallate ingestion.可能与服用次没食子酸铋相关的可逆性脑病。
Br Med J. 1974 Feb 9;1(5901):220-3. doi: 10.1136/bmj.1.5901.220.
4
Dose of influenza virus subunit vaccine.流感病毒亚单位疫苗剂量
Med J Aust. 1973 May 5;1(18):912-3. doi: 10.5694/j.1326-5377.1973.tb110788.x.
5
[Myoclonic and convulsive encephalopathy caused by bismuth. Usefulness of dimercaprol treatment].
Med Clin (Barc). 1985 Apr 6;84(13):530-2.
6
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.幽门螺杆菌相关的慢性活动性胃窦炎。关于其患病率以及抗菌和抗溃疡治疗效果的前瞻性研究。
Gastroenterology. 1988 Jan;94(1):33-40.
7
The clinical significance of Campylobacter pylori.幽门螺杆菌的临床意义。
Ann Intern Med. 1988 Jan;108(1):70-9. doi: 10.7326/0003-4819-108-1-70.
8
Neuropsychiatric symptoms following bismuth intoxication.铋中毒后的神经精神症状。
Postgrad Med J. 1988 Apr;64(750):308-10. doi: 10.1136/pgmj.64.750.308.
9
Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.幽门螺杆菌根除后十二指肠溃疡复发的前瞻性双盲试验
Lancet. 1988;2(8626-8627):1437-42. doi: 10.1016/s0140-6736(88)90929-4.
10
Myoclonic encephalopathy due to bismuth salts: treatment with dimercaprol and analysis of CSF transmitters.铋盐所致肌阵挛性脑病:用二巯丙醇治疗及脑脊液递质分析
Acta Neurol Scand. 1989 Mar;79(3):200-3. doi: 10.1111/j.1600-0404.1989.tb03739.x.

在接受三钾二枸橼酸铋治疗的患者中,D-青霉胺不会增加尿铋排泄。

D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate.

作者信息

Nwokolo C U, Pounder R E

机构信息

Academic Department of Medicine, Royal Free Hospital School of Medicine, London.

出版信息

Br J Clin Pharmacol. 1990 Oct;30(4):648-50. doi: 10.1111/j.1365-2125.1990.tb03829.x.

DOI:10.1111/j.1365-2125.1990.tb03829.x
PMID:2291879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1368261/
Abstract

Twenty-four urinary bismuth excretion was measured in five patients who had been treated with tripotassium dicitrato bismuthate, before and after single 1 g oral dose of D-penicillamine. Before dosing with D-penicillamine, the median 24 h urinary bismuth output was 55 micrograms 24 h-1 (range 17-156 micrograms 24 h-1) and following dosing with D-penicillamine the median 24 h urinary bismuth output was 53 micrograms 24 h-1 (range 12-156 micrograms 24 h-1). D-penicillamine does not facilitate the urinary excretion of bismuth, hence it is unsuitable for use as an oral chelator in patients with bismuth intoxication.

摘要

在5例曾用三钾二枸橼酸铋治疗的患者中,测定了单次口服1g D-青霉胺前后24小时尿铋排泄量。在给予D-青霉胺之前,24小时尿铋排泄量中位数为55微克/24小时(范围17 - 156微克/24小时),给予D-青霉胺后,24小时尿铋排泄量中位数为53微克/24小时(范围12 - 156微克/24小时)。D-青霉胺不能促进铋的尿排泄,因此它不适用于铋中毒患者作为口服螯合剂使用。